Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7CE9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,369
Award facts
- Contract value 100% obligated
- $14,368.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14.4K to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on January 9, 2026, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract reflects firm fixed pricing and is being fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. Wegovy is a diabetes and weight management medication, consistent with the pharmaceutical product categories that AmerisourceBergen routinely supplies to federal healthcare systems. The awardee operates as a subsidiary of Cencora, Inc., which does business as AmerisourceBergen and serves as the prime contractor for federal pharmaceutical procurement.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.9 million through December 2026, which functions as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs worldwide. The parent company, Cencora, Inc., holds an even larger IDC with DLA Troop Support Medical valued at up to $999.9 million through December 31, 2031, demonstrating the company's significant role as a critical pharmaceutical vendor for federal medical supply chains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F7CE9?
SPE2DR26F7CE9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F7CE9 worth?
The government has obligated $14,369 on SPE2DR26F7CE9.
Is contract SPE2DR26F7CE9 an order under another contract?
Yes. SPE2DR26F7CE9 is a delivery order under SPE2DR25D3504, an indefinite delivery contract.
Was contract SPE2DR26F7CE9 competed?
The extent of competition for SPE2DR26F7CE9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award